40mg lurasidone

DRUG2 trials

Sponsors

Sumitomo Pharma (Suzhou) Co., Ltd.

Conditions

Schizophrenia

Phase 1

Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects

CompletedNCT02174523

Sumitomo Pharma (Suzhou) Co., Ltd.Schizophrenia

Start: 2014-04-30End: 2014-04-30Updated: 2019-04-08

A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects

CompletedNCT02174510

Sumitomo Pharma (Suzhou) Co., Ltd.Schizophrenia

Start: 2014-03-31End: 2014-04-30Updated: 2019-01-11

Related Papers

Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects.

2017-09-019 citations